Daily Head and Neck Treatment Assessment for Optimal Proton Therapy Planning Robustness
Robust optimization in proton therapy ensures adequate target coverage; however, validation of fractional plan quality and setup uncertainty in patients has not been performed. We aimed to assess plan robustness on delivered head and neck proton plans classified into two categories: (1) primary only...
Main Authors: | Leslie Chang, Sherif G. Shaaban, Emile Gogineni, Brandi Page, Harry Quon, Heng Li, Rachel Ger |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-07-01
|
Series: | Cancers |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6694/15/14/3719 |
Similar Items
-
Designed and Validation of In-House Head and Neck Phantom for Quality Assurance and Radiotherapy Dose Measurements
by: mamta mahur, et al.
Published: (2023-09-01) -
Pencil‐beam scanning proton therapy for the treatment of glomus jugulare tumours
by: Jiří Kubeš, et al.
Published: (2022-12-01) -
Financial Toxicity in Head and Neck Cancer Patients Treated With Proton Therapy
by: Grace L. Smith, MD, PhD, MPH, et al.
Published: (2021-06-01) -
Knowledge-Based Planning for Robustly Optimized Intensity-Modulated Proton Therapy of Head and Neck Cancer Patients
by: Yihang Xu, et al.
Published: (2021-10-01) -
The Importance of Verification CT-QA Scans in Patients Treated with IMPT for Head and Neck Cancers
by: Jaden D. Evans, MD, et al.
Published: (2020-08-01)